Inner Mongolia Junzheng Energy & Chemical Group (601216.SH) elected Qiao Zhenyu as chairman.
Jinzheng Group (601216.SH) announced that the company's board of directors recently received resignations from the company's chairman, Zhang Haisheng, and vice president.
Inner Mongolia Junzheng Energy & Chemical Group (601216.SH) announced that the company's board of directors recently received resignation reports from the company's chairman, Zhang Haisheng, and the deputy general manager, Jing Haifeng. Due to work adjustments, Zhang Haisheng applied to resign from the positions of company chairman and chairman of the strategic committee. After resigning from the above positions, Zhang Haisheng will still serve as a director of the company, a member of the strategic committee, and a member of the audit and risk control committee. Due to work adjustments, Jing Haifeng applied to resign from the position of company vice general manager. After resigning from the above position, Jing Haifeng will still hold other positions in the company.
The company held the fourteenth meeting of the sixth board of directors on March 10, 2025, and approved the proposal for the election of the company's chairman. The meeting elected Qiao Zhenyu as the chairman of the company, who will also serve as the chairman of the strategic committee, with a term starting from the date of approval by this board of directors until the expiration of the term of the sixth board of directors. The board of directors agreed to appoint Li Kangjie as the company's vice general manager, with a term starting from the date of approval by this board of directors until the expiration of the term of the sixth board of directors.
Related Articles

ZHONGSHENJIANYE (02503): The subscription price has been changed to HKD 0.61 per share. Trading will resume at 1:00 pm on July 3rd.

SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.

SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.
ZHONGSHENJIANYE (02503): The subscription price has been changed to HKD 0.61 per share. Trading will resume at 1:00 pm on July 3rd.

SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.

SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.

RECOMMEND

U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025

Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025

Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025